Is BPSCX or JNJ a better dividend investment in 2026?

BPSCX currently yields 8.21% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BPSCX offers higher current income.

What is the dividend yield difference between BPSCX and JNJ?

BPSCX has a forward dividend yield of 8.21% ($1.94/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 4.85 percentage points.

Home › Compare › BPSCX vs JNJ

BPSCX vs JNJ: Dividend Comparison 2026

BPSCX yields 8.21% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BPSCX wins by $14.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BPSCX

● Live price

8.21%

Share price

$23.68

Annual div

$1.94

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.4K

Annual income

$1,379.96

Full BPSCX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BPSCX vs JNJ

📍 BPSCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BPSCX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BPSCX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BPSCX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSCX

Annual income on $10K today (after 15% tax)

$697.90/yr

After 10yr DRIP, annual income (after tax)

$1,172.97/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BPSCX beats the other by $469.35/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSCX + JNJ for your $10,000?

BPSCX: 50%JNJ: 50%

100% JNJ50/50100% BPSCX

Portfolio after 10yr

$27.2K

Annual income

$1,103.87/yr

Blended yield

4.05%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BPSCX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSCX buys

JNJ buys

No recent congressional trades found for BPSCX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBPSCXJNJ

Forward yield	8.21% ✓	3.36%
Annual dividend / share	$1.94	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$34.4K ✓	$20.0K
Annual income after 10y	$1,379.96 ✓	$827.78
Total dividends collected	$11.0K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BPSCX vs JNJ ($10,000, DRIP)

Year	BPSCX Portfolio	BPSCX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,521	$821.06	$10,676	$355.77	+$845.00 → BPSCX
2	$13,212	$884.06	$11,407	$389.39	+$1.8K → BPSCX
3	$15,084	$947.46	$12,198	$426.53	+$2.9K → BPSCX
4	$17,151	$1,010.97	$13,056	$467.62	+$4.1K → BPSCX
5	$19,426	$1,074.29	$13,987	$513.12	+$5.4K → BPSCX
6	$21,923	$1,137.18	$14,998	$563.56	+$6.9K → BPSCX
7	$24,656	$1,199.40	$16,098	$619.52	+$8.6K → BPSCX
8	$27,643	$1,260.72	$17,295	$681.69	+$10.3K → BPSCX
9	$30,899	$1,320.97	$18,599	$750.82	+$12.3K → BPSCX
10	$34,442	$1,379.96	$20,022	$827.78	+$14.4K → BPSCX

BPSCX vs JNJ: Complete Analysis 2026

BPSCX — Stock

The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective. The Advisor pursues the fund's objective by investing, under normal circumstances, at least 80% of its net assets (including borrowings for investment purposes) in a diversified portfolio consisting primarily of equity securities, such as common stocks of issuers with small market capitalizations and identified by the Adviser as having value characteristics. It may also invest up to 25% of its total assets in non U.S. dollar-denominated securities.

Full BPSCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BPSCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSCX vs SCHD BPSCX vs JEPI BPSCX vs O BPSCX vs KO BPSCX vs MAIN BPSCX vs ABBV BPSCX vs MRK BPSCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.